Publications by authors named "Helena Pujol"

Claim this Profile
C
Call for the National Boards of Health and the Maritime Administrations to introduce valid screening for type 2 diabetes at the maritime medical examinations.
Olaf Chresten Jensen, Victoria Corman, Maria Luisa Canals, David Lucas, Ilona Denisenko, Helena Estopà Pujol

Int Marit Health· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for type 2 diabetes and hypertension in seafarers' medical examinations.
Olaf Chresten Jensen, Agnes Flores, Victoria Corman, Maria Luisa Canals, David Lucas, Helena Estopà Pujol

Int Marit Health· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Navafenterol (AZD8871) in patients with mild asthma: a randomised placebo-controlled phase I study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending doses of this novel inhaled long-acting dual-pharmacology bronchodilator.
Eulalia Jimenez, Carol Astbury, Muna Albayaty, Ulrika Wählby-Hamrén, Beatriz Seoane, Helena Pujol

Respir Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety, and tolerability of once-daily abediterol in patients with stable, persistent asthma: a Phase II, randomized, 7-day, crossover study.
Jutta Beier, Rainard Fuhr, Beatriz Seoane, Eric Massana, Gonzalo de Miquel, Helena Pujol

Pharmacol Res Perspect· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abediterol, a novel long-acting β2-agonist: bronchodilation, safety, tolerability and pharmacokinetic results from a single-dose, dose-ranging, active-comparator study in patients with COPD.
Jutta Beier, Helena Pujol, Beatriz Seoane, Eulalia Jimenez, Carol Astbury

BMC Pulm Med· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting β2-adrenergic agonist, in asthma; a Phase II, randomized study.
Dave Singh, Helena Pujol, Anna Ribera, Beatriz Seoane, Eric Massana

BMC Pulm Med· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis